Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX, INC | Chief Medical Officer | Common Stock | 153K | $744K | $4.86 | Feb 5, 2024 | Direct |
OCULAR THERAPEUTIX, INC | Chief Medical Officer | Stock Option (Right to Buy) | 200K | Feb 3, 2024 | Direct | ||
Adverum Biotechnologies, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 44K | Aug 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADVM | Adverum Biotechnologies, Inc. | Aug 2, 2024 | 1 | $0 | 4 | Aug 6, 2024 | Chief Medical Officer |
ADVM | Adverum Biotechnologies, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Chief Medical Officer |
OCUL | OCULAR THERAPEUTIX, INC | Feb 3, 2024 | 3 | $30.8K | 4 | Feb 6, 2024 | Chief Medical Officer |
OCUL | OCULAR THERAPEUTIX, INC | Jan 31, 2024 | 1 | -$38.4K | 4 | Feb 2, 2024 | Chief Medical Officer |
OCUL | OCULAR THERAPEUTIX, INC | Jul 7, 2023 | 1 | -$4.1K | 4 | Jul 11, 2023 | Chief Medical Officer |
ADVM | Adverum Biotechnologies, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
OCUL | OCULAR THERAPEUTIX, INC | Feb 6, 2023 | 1 | -$27.2K | 4 | Feb 8, 2023 | Chief Medical Officer |
OCUL | OCULAR THERAPEUTIX, INC | Jan 30, 2023 | 3 | $0 | 4 | Feb 1, 2023 | Chief Medical Officer |
OCUL | OCULAR THERAPEUTIX, INC | Jul 1, 2022 | 4 | $0 | 4 | Jul 15, 2022 | Chief Medical Officer |
OCUL | OCULAR THERAPEUTIX, INC | Jul 1, 2022 | 0 | $0 | 3 | Jul 11, 2022 | Chief Medical Officer |
ADVM | Adverum Biotechnologies, Inc. | Mar 17, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Director |
ADVM | Adverum Biotechnologies, Inc. | Mar 17, 2022 | 0 | $0 | 3 | Mar 18, 2022 | Director |